SUBLINOX Trademark

Trademark Overview

On Friday, August 18, 2006, a trademark application was filed for SUBLINOX with the United States Patent and Trademark Office. The USPTO has given the SUBLINOX trademark a serial number of 79032312. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, August 19, 2016. This trademark is owned by OREXO AB. The SUBLINOX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of conditions and diseases connected to the central nervous system, such as pain, insomnia and migraine.
sublinox

General Information

Serial Number79032312
Word MarkSUBLINOX
Filing DateFriday, August 18, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, August 19, 2016
Registration Number3356648
Registration DateTuesday, December 18, 2007
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 2, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of conditions and diseases connected to the central nervous system, such as pain, insomnia and migraine.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 25, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOREXO AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSE
Party NameOREXO AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSE
Party NameOREXO AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE

Trademark Events

Event DateEvent Description
Friday, March 10, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, March 10, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, August 7, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, July 16, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, July 16, 2015INVALIDATION PROCESSED
Wednesday, March 25, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 25, 2014CANCELLED SECTION 71
Friday, December 19, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, April 8, 2008FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 8, 2008FINAL DISPOSITION PROCESSED
Monday, March 24, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 18, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, October 2, 2007PUBLISHED FOR OPPOSITION
Wednesday, September 12, 2007NOTICE OF PUBLICATION
Friday, August 24, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 24, 2007ASSIGNED TO LIE
Thursday, July 12, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 29, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 29, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 29, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 29, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 29, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 8, 2007REFUSAL PROCESSED BY IB
Tuesday, January 23, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 23, 2007REFUSAL PROCESSED BY MPU
Saturday, January 20, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 19, 2007NON-FINAL ACTION WRITTEN
Friday, January 12, 2007ASSIGNED TO EXAMINER
Friday, December 22, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, December 21, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

sublinox such system pain insomnia migraine nervous central treatment preparations conditions